Vascular endothelial growth factor-C (VEGF-C) is a more specific risk factor for lymph node metastasis than VEGF-D in submucosal colorectal cancer

Hepato-Gastroenterology

Volumn 54, Issue 73, 2007, Pages 71-76

  Kazama, Shinsuke ^a,c   Watanabe, Toshiaki ^a   Kanazawa, Takamitsu ^a   Hatano, Kenji ^b   Nagawa, Hirokazu ^a  

^a Faculty of Medicine   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Immunohistochemistry; Submucosal colorectal cancer; Vascular endothelial growth factor C (VEGF C); VEGF D

Indexed keywords

PARAFFIN; VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SUBMUCOSA;

AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 34047146390     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Tung SY, Wu CS, Wu MC, Su MY: Endoscopic treatment of colorectal polyps and early cancer. Dig Dis Sci 2001; 46:1152-1156.
2. Williams CB, Saunders BP, Talbot IC: Endoscopic management of polypoid early colon cancer. World J Surg 2000; 24:1047-1051.
3. Kudo S, Tamegai Y, Yamano H, Imai Y, Kogure E, Kashida H: Endoscopic mucosal resection of the colon: the Japanese technique. Gastrointest Endosc Clin N Am 2001; 11:519-535.
4. Muto T, Sawada T, Sugihara K: Treatment of carcinoma in adenomas. World J Surg 1991; 15:35-40.
5. Wilcox GM, Anderson PB, Colacchio TA: Early invasive carcinoma in colonic polyps. A review of the literature with emphasis on the assessment of the risk of metastasis. Cancer 1986; 57:160-171.
6. Morson BC, Bussey HJ, Samoorian S: Policy of local excision for early cancer of the colorectum. Gut 1977; 18:1045-1050.
7. Colacchio TA, Forde KA, Scantlebury VP: Endoscopic polypectomy: inadequate treatment for invasive colorectal carcinoma. Ann Surg 1981; 194:704-707.
8. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD: Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985; 89:328-336.
9. Nivatvongs S: Surgical management of early colorectal cancer. World J Surg 2000; 24:1052-1055.
10. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82:4-6.
11. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86:353-364.
12. Karkkainen MJ, Petrova TV: Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 2000; 19:5598-5605.
13. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Embo J 1996; 15:290-298.
14. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh Vw, Fang GH, Dumont D, Breitman M, Alitalo K: Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 1995; 92:3566-3570.
15. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, Alitalo K: VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 1996; 122:3829-3837.
16. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997; 276:1423-1425.
17. Yanai Y, Furuhata T, Kimura Y, Yamaguchi K, Yasoshima T, Mitaka T, Mochizuki Y, Hirata K: Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice. J Exp Clin Cancer Res 2001; 20:419-428.
18. Kurebayashi J, Otsuki T, Kunisue H, Mikami Y, Tanaka K, Yamamoto S, Sonoo H: Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. Jpn J Cancer Res 1999; 90:977-981.
19. Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S: Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res 2000; 6:2431-2439.
20. Tsurusaki T, Kanda S, Sakai H, Kanetake H, Saito Y, Alitalo K, Koji T: Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 1999; 80:309-313.
21. Yonemura Y, Endo Y, Fujita H, Fushida S, Ninomiya I, Bandou E, Taniguchi K, Miwa K, Ohoyama S, Sugiyama K, Sasaki T: Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 1999; 5:1823-1829.
22. Kabashima A, Maehara Y, Kakeji Y, Sugimachi K: Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma. Oncology 2001; 60:146-150.
23. Amioka T, Kitadai Y, Tanaka S, Harunia K, Yoshihara M, Yasui W, Chayama K: Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. Eur J Cancer 2002; 38:1413-1419.
24. Akagi K, Ikeda Y, Miyazaki M, Abe T, Kinoshita J, Maehara Y, Sugimachi K: Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer 2000; 83:887-891.
25. Furudoi A, Tanaka S, Haruma K, Kitadai Y, Yoshihara M, Chayama K, Shimamoto F: Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology 2002; 62:157-166.
26. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA: Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 1998; 95:548-553.
27. Baldwin ME, Catimel B, Nice EC, Roufail S, Hall NE, Stenvers KL, Karkkainen MJ, Alitalo K, Stacker SA, Achen MG: The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man. J Biol Chem 2001; 276:19166-19171.
28. White JD, Hewett PW, Kosuge D, McCulloch T, Enholm BC, Carmichael J, Murray JC: Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res 2002; 62:1669-1675.
29. Kazama S, Kitayama J, Watanabe T, Nagawa H: Expression pattern of Vascular Endothelial Growth Factor-C in human colorectal normal mucosa and neoplastic mucosa. Hepatogastroenterology 2004; 51:391-395.
30. George ML, Tutton MG, Janssen F, Arnaout AA, bulafi AM, Eccles SA, Swift RI: VEGF-A, VEGF-C, and VEGF-D in Colorectal Cancer Progression. Neoplasia 2001; 3:420-427.